BCM
HUMAW icon

Basso Capital Management’s Humacyte Inc Warrant HUMAW Stock Holding History

Basso Capital Management’s Portfolio HUMAW Stock Details HUMAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-17,666
Closed -$20K – 388
2020
Q4 		$20K Buy
+17,666
New +$16.7K 0.01% 186

Other funds holding HUMAW

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Basso Capital Management's HUMAW Position: Q1 2021 in Review

Basso Capital Management sold out of Humacyte Inc Warrant (HUMAW) in Q1 2021, closing a stake of 17,666 shares — an estimated $20K sold.

Basso Capital Management first reported a position in HUMAW in Q4 2020 and held it in 1 quarter. The position peaked at $20K in Q4 2020. 13 funds tracked by Wall St. Rank hold HUMAW as of Q1 2021.

  • Basso Capital Management reported no remaining Humacyte Inc Warrant position as of Q1 2021 after selling out during the quarter.
  • Basso Capital Management sold 17,666 Humacyte Inc Warrant shares in Q1 2021, an estimated $20K.
  • Basso Capital Management first reported a position in Humacyte Inc Warrant in Q4 2020 and held it in 1 quarter.
  • Basso Capital Management's Humacyte Inc Warrant position peaked at $20K in Q4 2020.
  • 13 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q1 2021.

Based on Basso Capital Management's 13F filing for Q1 2021, filed 10 May 2021.